NCI-MPACT: Molecular Profiling-Based Assignment of Cancer Therapy for Patients With Advanced Solid Tumors - Full Text View - ClinicalTrials.gov

NCI-MPACT: Molecular Profiling-Based Assignment of Cancer Therapy for Patients With Advanced Solid Tumors - Full Text View - ClinicalTrials.gov

NCI Trial to Explore Possible Benefit of Genetically Profiling Patients' Tumors

Would cancer patients benefit from receiving treatment that is assigned based on their tumor’s genetic profile? A new NCI clinical trial will seek to address this and other questions for patients with solid tumors.

•	Learn about NCI-MPACT (Molecular Profiling-based Assignment of Cancer Therapeutics)
•	NCI-MPACT trial description and contact information